Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Esomeprazole in Psoriasis
NCT02624544Phase 4Withdrawn
- Sponsor
- EMS
- Start
- Jan 2016
- Primary completion
- Jan 2016
- Modality
- Small Molecules
01
Overview
A Phase 4 trial of esomeprazole in psoriasis, sponsored by EMS. Planned start Jan 2016; status: withdrawn.
02
Drugs
esomeprazole
03
Conditions
psoriasis
Beyond the preview
Go deeper on NCT02624544.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02624544.